Clinical Trial Update: Hyperinsulinemia in Prediabetes Mediated by Interleukin-1β [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating interleukin-1β–mediated hyperinsulinemia in individuals with prediabetes has completed. The update provides the status and results of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperinsulinemia
• Prediabetes

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Hyperinsulinemia, PreDiabetes | Phase 2 | Status: COMPLETED